依托三酯
塞来昔布
医学
头痛
不利影响
麻醉
恶心
内科学
药理学
外科
作者
Mena Farag,Anish Bahra
出处
期刊:Headache
[Wiley]
日期:2022-03-01
卷期号:62 (3): 383-388
被引量:6
摘要
Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches. Many patients show a rapid therapeutic response to indomethacin, which is limited by intolerability. Etoricoxib and celecoxib, selective inhibitors of cyclo-oxygenase-2 (COX-2), spare gastroduodenal COX-1 activity and are less likely to cause gastrointestinal adverse effects than indomethacin. We report a case series of eight patients, seven who responded to etoricoxib and one patient who responded to celecoxib.
科研通智能强力驱动
Strongly Powered by AbleSci AI